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a b s t r a c t
Sequence analyses of inﬂuenza PB2 sequences indicate that the 627 position almost exclusively contains
either lysine (K) or glutamic acid (E), suggesting a high sequence constraint at this genetic marker. Here,
we used a site-directed random mutagenesis method to demonstrate that PB2-627 position has a high
sequence plasticity. Recombinant viruses carrying various amino acid residues at this position are viable
in cell cultures. These PB2-627 mutants showed various polymerase activities and replication kinetics in
mammalian and avian cells as well as pathogenicity in mice. Serially passaging these mutants in MDCK
cells generated some compensatory PB2 mutations that can restore polymerase activities of the PB2-627
mutants. Of these, PB2-D309N was identiﬁed as a novel one. Besides showing that inﬂuenza virus can
tolerate a wide range of amino acid residues at the PB2-627 position, this study also demonstrates a
potential strategy to identify novel mutations that can enhance viral polymerase.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Viral polymerase of inﬂuenza A viruses is important for modulating
virus replication kinetics, host speciﬁcity and pathogenicity (Gabriel
et al., 2005; Naffakh et al., 2008; Zhu et al., 2012). Among the three
viral polymerase subunits, PB2 is the largest one and it has binding
sites for both PB1 and NP at its N-terminus and C-terminus, respec-
tively (Poole et al., 2004). It contains nuclear localization signal (NLS)
and is transported independently into the nucleus (Huet et al., 2010;
Mukaigawa and Nayak, 1991; Tarendeau et al., 2007). Functionally, PB2
binds to the 50 cap of the host mRNA for obtaining a cap primer for
viral transcription initiation. Several genetic markers of PB2 are
associated with host adaptation. There has been evidence showing
that PB2-E627K mutation is one of the genetic markers leading to
enhanced polymerase activity, host adaptation and enhanced viru-
lence (Hatta et al., 2001; Labadie et al., 2007; Massin et al., 2001;
Shinya et al., 2004; Subbarao et al., 1993). In general, avian PB2 has a
Glu (E) residue at position 627 and replacing this amino acid residue
with a Lys (K) can enhance the polymerase activity of an avian vRNP in
mammalian cells. This makes PB2-E627K mutation as one of the most
important markers for predicting the ﬁtness of an avian virus in
mammal hosts. Studies further show that this 627K/E polymorphism
can affect viral RNA synthesis (Paterson et al., 2014) and the binding of
vRNP to cellular importin (Hudjetz and Gabriel, 2012). On the other
hand, the PB2 D701N mutation also alters the binding ability of PB2 to
cellular importin, thereby affecting the nuclear localization pattern of
PB2 (Boivin and Hart, 2011; Gabriel et al., 2008). Recently, PB2-590 and
591 residues found in the pandemic H1N1/2009 virus were shown to
enhance viral replication and virus virulence in mammalian hosts (Liu
et al., 2012; Mehle and Doudna, 2009).
In the case of PB2 sequences available from public databases, the
majority of inﬂuenza viral PB2 proteins possess either a K or E at this
position (99.6%, total number of analyzed viral sequences¼19,469;
personal observations). It is therefore highly logical to study PB2
proteins, vRNPs or recombinant viruses carrying this PB2-627K/E
polymorphism. However, it is evident that there is a lack of systematic
mutagenic studies of this important position. In addition, there is a
small and yet signiﬁcant number of inﬂuenza PB2 segments that have
a valine (V) at this position (Davidson et al., 2013; Golender et al.,
2008). It is not known whether vRNPs with an atypical amino acid
residue at this position behave differently from those carrying a K or E
at the same position. In particular, it is of our interest to determine
whether introducing atypical amino acid residues at the PB2-627
position would lead to viable viruses and whether such mutations
would affect the viral polymerase activity and viral ﬁtness.
Here, we applied a random mutagenesis method to create a
number of inﬂuenza viruses with different point mutations at the
PB2-627 position. These PB2 mutants are characterized both in vitro
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and in vivo conditions. In addition, their polymerase activities were
also determined by using a reporter gene assay for inﬂuenza
polymerase. Our results indicate that the phenotypes of these viruses
and genetic stabilities of these mutations are different.
Results
Generation of recombinant viruses with mutation at PB2-627
The primary objective of this study is to determine the sequence
plasticity of PB2-627 position. A laboratory-adapted strain (A/Puerto
Rico/8/1934; PR8) is used as the prototype virus of this study.
Recombinant viruses were generated by a plasmid-based reverse
genetic system (Hoffmann et al., 2000) (Fig. 1). An inverse PCR
technique was used to introduce random mutations at the PB2-627
in the PB2 expression plasmid as described in the Materials and
Methods section (Dominy and Andrews, 2003; Valetti and Gilardi,
2013). Previous studies have demonstrated that viral particles with
a defective polymerase gene can be generated by reverse genetics
(de Wit et al., 2006; Ozawa et al., 2011), indicating the formation of
virions in transfected human embryonic kidney 293T cells is
independent of the functionality of inﬂuenza viral polymerase
complex. Infectious mutants generated from transfected 293T cells
were ampliﬁed in Madin–Darby canine kidney (MDCK) cells and 10-
day-old chicken embryonated eggs, followed by plaque puriﬁcation
using MDCK cells (hereafter called as “mammalian system”) and
chicken ﬁbroblast DF-1 cells (hereafter called as “avian system”),
respectively.
In the mammalian virus culturing system, a total of 41 puriﬁed
viral clones were randomly selected from three independent trans-
fection experiments. These mutants were found to contain a total of 7
different amino acid residues, including Ala (A), Ile (I), K, Leu (L), Arg
(R), Ser (S) and Val (V), at the PB2-627 position (Table 1). In contrast, 17
plaque puriﬁed clones cultured in the avian system were selected for
further characterization. These recombinants were obtained from a
single transfection experiment and were found to contain A, Cys (C),
K and Glu (Q) at the PB2-627 position (Table 1). Overall, 9 different PB2
mutant viruses were rescued, with PB2-627A and PB2-627K mutants
derived from both mammalian and avian systems. Apart from the
introduced mutations, no mutationwas detected in other PB2 regions.
These results suggest that there is high sequence plasticity at the PB2-
627 position and that a K or E residue at this position is not absolutely
essential for viruses to propagate in cell lines.
Effect of PB2-627 on polymerase activity of vRNPs in mammalian
and avian cells
The PB2-627 K/E polymorphism is known to modulate viral
polymerase activities in mammalian and avian cells. To study
whether the identiﬁed PB2-627 mutations would affect viral
polymerase activities, the PB2 segment from each of these recom-
binant viruses was individually cloned and tested for its activities
in two luciferase reporter assays (1 for mammalian cells and 1 for
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Identification of amino acid at PB2-627 by DNA sequencing
Characterization of PB2-627 mutants
Fig. 1. Schematic diagram showing the methodology of generating recombinant viruses with random mutations at PB2-627.
Table 1
PB2-627 mutants generated in this study.
Cell PB2-627 mutation Number (%)
MDCK A 7 (17.1%)
I 2 (4.9%)
K 3 (7.3%)
L 8 (19.5%)
R 18 (43.9%)
S 1 (2.4%)
V 2 (4.9%)
DF-1 A 2 (11.8%)
C 3 (17.6%)
K 8 (47.1%)
Q 4 (23.5%)
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avian cells) (Li et al., 2009). Recombinant vRNPs of these viruses,
together with a control vRNP carrying PB2-627E, were reconsti-
tuted in mammalian 293T cells and avian DF-1 cells. The trans-
fected cells were incubated at 37 1C and 39 1C, which mimic the
core temperatures of human and chicken hosts, respectively.
In transfected 293T cells incubated at 37 1C, vRNPs with PB2-
627K and PB2-627E had the highest and lowest polymerase
activities, respectively (Fig. 2A). With the exception PB2-627R
and PB2-627A mutants, all vRNP mutants (I, L, S, Q and C) caused
various degrees of reduction of polymerase activities. At 39 1C, all
the vRNPs had further reduction of polymerase activity compared
with the wild-type level (PB2-627K), but the overall pattern of
these reductions was similar to those observed at 37 1C. In
contrast, there were less variations of viral polymerase activity
observed in the DF-1 cells (Fig. 2B). At 37 1C, vRNPs carrying I, R, S,
V, C and E at PB2-627 positions were found to be less active in the
reporter assays, but these mutants still had at least 50% of the
wild-type activity. At 39 1C, the majority of these vRNPs had
activities comparable to those observed at 37 1C. Interestingly,
2 of these vRNP mutants (PB2-627A and 627C) were found to have
enhanced polymerase activities at 39 1C, although these were not
signiﬁcantly different from the wild-type level. It is important to
note that PB2-627A and PB2-627C were those identiﬁed from
recombinant viruses rescued in avian cells (Table 1).
It is interesting to note that the polymerase activities of these
PB2 mutants in transfected 293T cells are positively correlated
with the isoelectric point (pI value) of the introduced amino acid
residues (37 1C, R2¼0.72; 39 1C, R2¼0.76). This suggests that the
polymerase activity of vRNP can be inﬂuenced by the net charge of
PB2-627 residue in 293T cells. The more positive the charge at
PB2-627 residue is, the higher the polymerase activity will be.
However, this correlation was not observed in vRNPs constituted
in DF-1 cells at 37 1C or 39 1C (37 1C, R2¼0.01; 39 1C R2¼0.02),
suggesting the correlation between pI value of PB2-627 amino acid
residue and viral polymerase activity is host or cell type speciﬁc.
Overall, vRNPs with different amino acids at PB2-627 showed
different polymerase activities in different host cells. It was also
observed that temperature can affect viral polymerase activity and
this response is cell type dependent.
Effect of PB2-627 on growth kinetics of recombinant viruses
in mammalian and avian cells
To determine whether the identiﬁed PB2-627 mutations would
have effects on virus replications, growth kinetics of these recom-
binant viruses were characterized in mammalian MDCK and avian
DF-1 cells at two different temperatures. Viral growth kinetics of
mutants obtained from the mammalian system, i.e. K (wild-type),
A, I, L, R, S and V, were ﬁrst characterized in MDCK cells at 37 1C
and 39 1C. At 37 1C, all recombinant viruses had growth rates
similar to the wild-type level (Fig. 3A). However, at 39 1C, PB2-
627L mutant was found to have a signiﬁcantly reduced growth
kinetic and its titer at 72 h post-infection was about 2 logs lower
than that of the PB2-627K virus (Fig. 3B). In addition, PB2-627A,
627S and 627V mutants were also found to have moderate but
signiﬁcant reductions in viral titers compared with the PB2-627K
virus (Fig. 3B). Recombinant PB2 mutants generated in the avian
system (i.e. K (wild-type), C and Q) and an additional site-directed
PB2 control mutant carrying the avian PB2-627E marker were also
characterized in the MDCK cells in the same manner. At 37 1C, both
PB2-627Q and PB2-627E mutants were found to have slightly
reduced replication kinetics than the wild-type PB2-627K virus
(Fig. 3C). The effects of these mutations on virus replication
kinetics were more pronounced when infected cells were incu-
bated at 39 1C. Under these experimental conditions, PB2-627Q
and PB2-627C mutants were found to have about 1 and 2 log
reductions, respectively, in viral titers, compared with the wild-
type level (Fig. 3D).
To investigate the effects of these mutations on virus replica-
tion in avian cells, representative mutants generated from the
mammalian (A, K, L, R and V) and avian (K, C and Q) systems were
characterized in avian DF-1 cells (Fig. 4). Of the viruses generated
from the mammalian system, the PB2-627R mutant had the most
signiﬁcant retardation in growth rates compared with the wild-
type levels at both 37 1C and 39 1C (Fig. 4A and 4B). Interestingly,
the PB2-627L mutant, which had a reduced replication rate in
MDCK cells, was found to have a signiﬁcant increase of virus titer
compared with the wild-type at both temperatures. The growth
kinetics of PB2-627A and PB2-627V mutants were found to be
similar to the wild-type. Of the mutants generated from the avian
system, viruses PB2-627K, PB2-627C and PB2-627Q had similar
replication kinetics at both temperatures, whereas the PB-627E
control virus had the highest replication kinetic in DF-1 cells.
The above results overall demonstrate that inﬂuenza viral
polymerase activity might not necessarily correlate with virus
replication kinetics. Mutants that have highly reduced viral poly-
merase activities might have robust virus replication rates in cells,
whereas some mutants that have moderate polymerase activities
were found to have highly reduced virus replications (e.g. PB2-
627L vs PB2-627S in MDCK cells at 39 1C). Nonetheless, mutants
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Fig. 2. Effect of PB2-627 mutations on relative polymerase activity of PR8 vRNP
complexes in mammalian and avian cells at different temperatures. Mutated vRNP
complexes were reconstituted in mammalian 293T cells (A) and avian DF-1 cells
(B) at 37 1C (black) and 39 1C (white). Polymerase activities were determined by
luciferase reporter assays and were normalized by GFP expression. The normalized
results are expressed as mean relative polymerase activity in relative to wild-type
PR8 vRNP (PB2-627K) at the corresponding cell type and temperature. Mock
represents the negative control without vRNP complexes. Error bars represent
one standard deviation (N¼3, npo0.05, by t-test).
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derived from the mammalian system generally had larger varia-
tions in virus titers in DF-1 cells (Fig. 4A), but their titers in MDCK
cells at 37 1C were found to be comparable (Fig. 3A). In contrast,
mutants derived from the avian system generally had larger
variations in virus titers in infected MDCK cells at 39 1C (Fig. 3D),
but their titers in DF-1 cells at the same incubation temperature
were found to be similar (Fig. 4D).
Some recombinant viruses are less virulent in mice and are
genetically unstable
To determine the virulence of these mutants in mice, all recom-
binant viruses rescued from the mammalian and avian systems
together with the PB2-627E control mutant were used to infect mice
via intranasal route with a dose of 1000 TCID50 (3 MLD50 of wild-
type virus). The wild-type PB2-627K virus was found to be the most
virulent in mice and PB2-627I, 627R and 627E mutants were found
to be more virulent than the other PB2 mutants in terms of weight
loss and mortality rate (Fig. 5A and B). Mice infected with PB2-627K,
627I, 627R and 627E mutants (N¼6 per group) had the most
dramatic weight loss at day 3 post-infection (Fig. 5A) and met the
experimental endpoint (430% of weight loss) at or before day 8
post-infection (Fig. 5B). In contrast, mice infected with other mutant
viruses (PB2-627L, 627A, 627S, 627V, 627C and 627Q) had only
moderate, if any, weight loss at the early post-infection time points.
However, these infected mice started to have weight loss at day 5
post-infection and about 70–100% of these mice reached the experi-
mental endpoint at the second week of post-infection (Fig. 4A and B).
Some of the representative PB2 mutants were selected for
further characterization in mice. Mice were initially infected by the
wild-type PB2-627K virus or its mutant (PB2-627I, 627R, 627C or
627E) with a dose of 1000 TCID50 and the infected mice were
checked for lung virus titers at day 3 and day 6 post-infection
(N¼3 per group). It was observed that PB2-627C mutant, which is
less virulent in mice, replicated less well than the PB2-627K virus
in mouse lungs (Fig. 5C). Of the 3 mutants that have virulence
comparable to the wild-type virus, PB2-627I and PB2-627R
mutants yielded lung virus titers similar to the wild-type at both
the studied time points. In contrast, PB2-627E, which initially had
a wild-type level at day 3 post-infection, produced less virus titers
than the wild-type virus in mouse lungs at day 6 post-infection.
Based on the weight loss and mortality rates observed in the
infected mice (Fig. 5A and B), these PB2 mutants generated from
our random mutagenesis can generally be classiﬁed into two
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* Viral titer significantly different from 627K at 12 h post infection (p<0.05).
# Viral titer significantly different from 627K at 24 h post infection (p<0.05).
Viral titer significantly different from 627K at 48 h post infection (p<0.05).
¶ Viral titer significantly different from 627K at 72 h post infection (p<0.05).
Fig. 3. Effect of PB2-627 mutations on growth kinetics of recombinant PR8 viruses in MDCK cells at different temperatures. MDCK cells were infected by PB2-627 mutants
derived from the mammalian system (A and B) or the avian system (C and D) at MOI of 0.01. The cells were incubated at 37 1C (A and C) or 39 1C (B and D). Supernatants were
harvested at 12 h, 24 h, 48 h and 72 h post-infection, and were subjected to standard plaque assay with MDCK cells for determination of viral titers. Error bars represent one
standard deviation (N¼3). Signiﬁcant differences as compared with the wild-type virus are indicated by n for 12 h, # for 24 h, § for 48 h and ¶ for 72 h post-infection
(po0.05, by t-test).
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groups: 1) those that can cause rapid weight loss and death in the
ﬁrst week post-infection; and 2) those that can cause mild weight
loss in the ﬁrst week but death in the second week. To determine
whether these PB2 mutations are still genetically stable after a
single passage in mice, the PB2 genes of these viruses were
sequenced at the stage where the mice were close to the experi-
mental endpoints (day 6 post-infection for PB2-627K, 627I and
627R; day 12–14 post-infection for PB2-627L, 627S, 627V, 627A,
627C and 627Q; N¼2 per virus). The 627I and 627R mutations,
together with the wild-type PB2 627K residue, were found to be
stable in mice and no mutation was detected at this position at the
experimental endpoint. Strikingly, samples from mice infected
with PB2-627L, 627S, 627A, 627C and 627Q were all found to
have mutations at the PB2 627 position and each of these samples
were mixtures of viruses containing an E, a K or the introduced
mutation at the position. For mice infected with PB2-627V mutant,
the samples were found to contain mixture of viruses carrying the
introduced mutation or an E at this position. The detection of K
and/or E at PB2-627 might also explain why mice infected with the
second group of mutants (PB2-627L, 627S, 627V, 627A, 627C and
627Q) died in the second week post-infection.
Genetic stability of mutations at PB2-627 residues in MDCK cells
In order to further investigate the genetic stability of these PB2
627 mutations, the PB2 mutants were serially passaged in MDCK
cells at 37 1C and 39 1C in duplicate with initial infection at MOI of
0.01. The PB2 genes of these mutants were sequenced after 10
serial passages. Interestingly, all PB2 mutations were found to be
genetically stable in all experiments. None of these mutants has
PB2-627E or 627K mutation as observed in the above in vivo
experiments. Instead, some of the mutants were found to acquire
additional mutations in other PB2 regions (Table 2). In general,
mutants passaged at 39 1C were found to be more likely to have
additional mutations than those passaged at 37 1C. It is also
interesting to note that some of these mutations could be identiﬁed
more than once, either from independent passages of the same
mutant or from passages of different PB2-627 mutants. Mutations
A152V and Q591K were reproducibly found in progeny viruses of
PB2-627V and PB2-627E mutants, respectively, at different incuba-
tion temperatures, whereas mutations D309N, I504V and D701N
were reproducibly found in different PB2 mutants passaged at a
speciﬁc temperature.
Viruses derived from MDCK cells
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Fig. 4. Effect of PB2-627 mutations on growth kinetics of recombinant PR8 viruses in DF-1 cells at different temperatures. DF-1 cells were infected by PB2-627 mutants
derived from the mammalian system (A and B) or the avian system (C and D) at MOI of 0.1. The cells were incubated at 37 1C (A and C) or 39 1C (B and D). Supernatants were
collected at 12 h, 24 h and 72 h post-infection, and were subjected to standard plaque assay with MDCK cells for determination of viral titers. Error bars represent one
standard deviation (N¼3). Signiﬁcant differences as compared with the wild-type virus are indicated by n for 12 h, # for 24 h and ¶ for 72 h post-infection (po0.05, by
t-test).
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To determine the impacts of these ﬁve reproducible mutations
on viral polymerase activity, they were individually introduced
into the corresponding PB2-627 mutants. These double mutants
were then characterized by the viral polymerase reporter assay as
described above. Four of the selected mutations (D309N, I504V,
R591K and D701N) were found to enhance the viral polymerase
activity compared with the corresponding controls (Fig. 6). In
particular, PB2-627 mutants carrying D309N or I504V were found
to have polymerase activities that are higher than the wild-type
level (PB2-627K). However, the introduction of PB2-A152V to the
PB2-627V mutant was found to have no effect on viral polymerase
activity.
PB2-D309N mutation alone can enhance polymerase activity
of mammalian and avian vRNPs
Among the 4 compensatory mutations that can restore or
partially restore the polymerase activity of above PR8 PB2-627
mutants, there has been no previous report on the biological
functions of PB2-D309N (see Discussion). In order to investigate
the effect of this mutation alone on the polymerase activity, the
D309N mutation was introduced into wild-type PB2 of PR8 by site-
directed mutagenesis. The polymerase activity of the mutant vRNP
was compared with the wild-type vRNP at 37 1C and 39 1C. The
result indicated that PB2-D309N mutation alone can enhance the
polymerase activity of PR8 vRNP at 37 1C and 39 1C (Fig. 7A).
To test whether the PB2-D309N mutation can also stimulate the
viral polymerase activity of an avian vRNP, this mutation was
introduced into the PB2 of an avian strain (A/Quail/HK/G1/1997, G1;
H9N2). The polymerase activity of the mutant G1 vRNP was compared
with the wild-type G1 vRNP at 37 1C and 39 1C (Fig. 7B). Similar to the
result of PR8 vRNPs, the PB2-D309N mutation enhance the polymer-
ase activity of G1 vRNP by about two folds at 37 1C. At 39 1C, the
polymerase activity of the mutant vRNP also enhanced, albeit with a
lower enhancement compared to that in the PR8 background. These
results demonstrated that PB2-D309N mutation can enhance poly-
merase activity of human and avian vRNPs.
Discussion
PB2-627 is a well-known genetic marker for host adaptation,
virulence and transmission (Hatta et al., 2001; Herfst et al., 2012;
Imai et al., 2012; Naffakh et al., 2008; Steel et al., 2009; Subbarao
et al., 1993). However, most of the studies have focused on PB2-627K
and 627E, which are the prevailing amino acids at this position in
human and avian viruses, respectively. Using a targeted random
mutagenesis approach, we created a panel of viable viruses with
different amino acid residues at the PB2-627 position (Table 1).
Surprisingly, our results demonstrated that the inﬂuenza viral poly-
merase can accommodate a wide range of amino acids residues at
this position (i.e. acidic, basic, aliphatic, sulfur-containing and hydro-
xyl amino acid residues). These mutants exhibited distinct properties
in different experimental settings and the mutations were at least
stable under the in vitro conditions.
The viral polymerase reporter assays showed that PR8 vRNP
possessing PB2-627K had the highest polymerase activity and the
control mutant with an avian signature at the PB2 627 position
(PB2-627E) had the lowest polymerase activity in human 293T
cells (Fig. 2A). This is in agreement with previous ﬁndings in that
PB2-E627K mutation enhances polymerase activity in mammalian
Fig. 5. Effect of PB2-627 mutations on virulence of recombinant PR8 viruses in
mice. Six BALB/c mice per group were infected by PB2-627 mutants via intranasal
route at a dose of 1000 TCID50 per mouse. Mice inoculated with PBS were used as
uninfected control. (A) Body weight of the mice were measured daily for 14 days
and are presented as relative to their initial body weight. Error bars represent one
standard deviation (N¼6). Signiﬁcant differences as compared with the wild-type
virus infected mice are indicated by n for day 2 post-infection, # for day 3 post-
infection, § for day 4 post-infection, ¶ for day 5 post-infection and ^ for day 6 post-
infection (po0.05, by t-test). (B) Survival rate of six mice per group was also
recorded. Mice with weight loss of more than 30% of the initial body weight were
humanely euthanized. (C) Three mice per group were infected by the recombinant
viruses with different amino acids at PB2-627 position via intranasal route at a dose
of 1000 TCID50 per mouse. The mice were humanely euthanized on day 3 or day
6 post-infection. Their lungs were collected and were homogenized in ice-cold PBS.
Viral titers of the whole lung homogenates were determined by standard TCID50
assay with MDCK cells. Error bars represent one standard deviation (N¼3).
Signiﬁcant differences as compared with the wild-type virus infected mice are
indicated by n (po0.05, by t-test).
Table 2
PB2 mutations identiﬁed in PB2-627 mutants after 10 serial passages in MDCK cells.
PB2-627 mutant Additional PB2 mutations after serial passages
37 1C 39 1C
627K Nil Nil
627I Nil D153N, I504V
627L Nil R436K
627R E487G I504V
627S D701N Nil
627V A152Va, D701Na, D740N A152V, D309N
627A Nil D309N, R349K
627Q Nil I504V
627C Nil M81K, T106A
627E Q591Ka Q591Ka
a Mutations reproducibility found in passaged PB2 mutants.
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cells (Labadie et al., 2007; Moncorge et al., 2010; Naffakh et al.,
2000). The novel PB2 mutants generated from this work were
found to have polymerase activities in between those PB2-627K
and PB2-627E in 293T cells. Previous studies of the PB2-627K/E
polymorphism showed that a PB2-K627E mutation disrupts a
prominent basic surface patch located at the PB2-627 domain
(Tarendeau et al., 2008). It is possible that the surface charge
difference of the 627-domain of PB2 is a determining factor of
polymerase activity. This hypothesis is supported by our observa-
tions that the viral polymerase activity in 293T cells is positively
correlated with the pI value of the introduced amino acid muta-
tion. However, this correlation was not observed from data
deduced from avian DF-1 cells. These ﬁndings agree with previous
ﬁndings that the host restriction due to PB2-627K/E polymorph-
ism is observed in mammalian, but not in avian, cells (Labadie
et al., 2007; Mehle and Doudna, 2008).
In this study, a few PB2-627 mutants were found to have distinct
properties under certain experimental settings. We sequenced the
PB2, PB1, PA and NP genes of plaque-puriﬁed mutant that were
subsequently found to have interesting phenotypes. Speciﬁcally,
mutants that have pathogenicity comparable to the wild-type virus
(PB2-627R, 627E and 627I) and mutants that have the high (PB2-
627A) or low (PB2-627C, 627S) polymerase activities were selected
for the additional sequencing analyses. No mutation was identiﬁed
in the studied mutants, suggesting that our observations were
primarily due to the introduced mutations.
Amongst these PB2-627 mutants, PB2-627R had the highest
polymerase activity in 293T cells but it had the lowest activity in
DF-1 cells. Mutations selected by the avian system (e.g. PB2-627A,
627C and 627Q) were found to have polymerase activities similar
to the wild-type PB2-627K in DF-1 cells at 39 1C, but they had
variable activities in 293T cells. These results suggest that some of
Fig. 6. Effect of additional mutations on the polymerase activity of PB2-627 mutants. PB2 mutations that were reproducibly found in passaged PB2 mutants were introduced
into the corresponding PB2-627 mutants by site mutagenesis to generate PB2 double mutants. The double mutants were reconstituted in 293T cells at 37 1C (A) and 39 1C (B).
Polymerase activities were determined by luciferase reporter assays and were normalized by GFP expression. The normalized results are expressed as mean relative
polymerase activity in relative to wild-type PR8 vRNP (PB2-627K) at the corresponding temperature. Mock represents the negative control without vRNP complexes. Error
bars represent one standard deviation (N¼3, npo0.05, by t-test).
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the PB2-627 mutations might affect the viral polymerase in a
conditional manner. The mechanism accounts for their unique
properties are yet to be determined. Nevertheless, this panel of
mutants would be a useful tool to study the role of PB2-627
position in some speciﬁc functions, such as vRNA promoter
binding, of inﬂuenza viral polymerase.
The growth kinetics of these viruses were not fully correlated
with their polymerase activities, suggesting that viral polymerase
activity is normally not a rate-limiting factor for virus replication.
However, viruses that were found to have much reduced replica-
tion kinetics also showed reduced polymerase activities at the
corresponding conditions (e.g., PB2-627C in mammalian cells at
39 1C and PB2-627R in avian cells). We also noted that the PB2-627
mutants generated from the mammalian system yielded more
variable titers in DF-1 cells at 37 1C. PB2-627 mutants generated
from the avian system cultured in MDCK cells at 39 1C displayed
similar behaviors (Figs. 3 and 4). We reason that when the
mammalian-derived PB2-627 mutants were cultured under a
condition very different from the original culturing condition (i.e.
DF-1 cell at 39 1C vs MDCK cells at 37 1C), some of these mutants
might not achieve robust virus replications under such “unfavor-
able” conditions. This possible explanation can also apply to PB2
mutants generated from the avian system. These ﬁndings support
the hypothesis that different hosts might have different tolerances
to or preferences for amino acids at this PB2 position. It is of
interest to use the same study approach to generate PB2-627 avian
virus mutants to test this hypothesis and validate our ﬁndings in
future. In addition, we do not exclude the possibility that our
observations may also be affected by the cell type used in our
models.
Of the 58 plaque puriﬁed clones generated in the study, none of
these recombinant viruses were found to contain E at the PB2-627
position (Table 1). This result is rather surprising and does not
entirely agree with observations found in nature. In addition, our
results indicate that the PB2-627E control mutant achieved robust
virus replications in our experiments (Figs. 3 and 4). PB2-627E
mutant alone can form distinct viral plaques in standard plaque
assays, indicating that the failure of detection of PB2-627E mutant
was not an artefact caused by the clone isolation method. One,
however, should note that viral polymerase with PB2-627E was
shown to have the lowest polymerase activity in the luciferase
reporter assays. It is possible that the poor polymerase activity of
PB2-627E mutant is the limiting factor that accounts for our
observations in the virus rescue work.
For other mutations that were not detected in the rescued
viruses, it is possible that mutants with these mutations might
have poor plaque forming ability and cannot be isolated by plaque
puriﬁcation. Alternatively, mutants with these mutations might
also have highly reduced polymerase activities and could not
complete with other mutants in the initial virus cultures. Other
study approaches, such as use of limiting dilution methods for
clone isolation and increase sampling size in the initial screening,
may be useful to test the above hypotheses.
Although the PB2-627E mutation might reduce virus polymer-
ase activity, the amino acid clearly has an unknown advantage for
inﬂuenza virus in infected cells. Both in vitro and in vivo data
revealed that the mutant virus with PB2-627E does not compro-
mise as much as some other mutants do in terms of replication
ability and pathogenicity. We sequenced the whole vRNP complex
and no compensatory mutation was found in the PB2-627E
mutant. For all PB2 mutants that caused delayed disease onset in
mice (PB2-627L, S, V, A, C and Q), they were found to have
generated progeny viruses with PB2-627E in the lungs. The
potential beneﬁts of acquiring PB2-627E mutation in these
mutants are not known. With the results obtained from our
in vitro data, we speculate that the acquisition of PB2-627E
mutation might have beneﬁts other than regulating viral RNA
polymerase activity itself. For example, PB2 is known to have effect
on degradation of host RNA polymerase II. Further characterization
of this panel of PB2 mutants might help to understand the role of
PB2-627 in the virus lifecycle. Nonetheless, our data demonstrated
that there is a much more stringent amino acid requirement at this
position under the in vivo conditions. This might also explain why
animal inﬂuenza viruses found in nature predominantly have an E,
if not K, at this position.
Of the six mutants that could generate PB2-627E mutation in
mice, ﬁve also generated progeny viruses with PB2-627K mutation
in the same infected mice. It is not known whether these PB2-
627E and PB2-627K mutations occurred independently or sequen-
tially. Previous studies have demonstrated that the PB2-E627K
mutation can occur in mice (Bogs et al., 2011). These previous
results highly suggest that the mutations of our PB2 mutants in
mice occurred in a sequential manner, with the mutants ﬁrst
acquiring a PB2-627E mutation, followed by a PB2-E627K muta-
tion. The PB2-627I and PB2-627R mutants had virulence similar to
PB2-627E in mice. No mutation was detected in mice infected with
PB2-627I and PB2-627R at the experimental endpoint. Besides, it is
interesting to note that PB2-627I mutant, which does not carry a
charged amino acid side chain at the PB2-627, was also shown to
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Fig. 7. Effect of PB2-D309N mutation on the polymerase activity in vRNPs of
different genetic backgrounds. PB2-D309N mutation was introduced into PR8
(human H1N1; A) or G1 (avian H9N2; B) vRNP. The wild-type and mutant vRNPs
were reconstituted in 293T cells at 37 1C (black) and 39 1C (white). Polymerase
activities were determined by luciferase reporter assay and were normalized by
GFP expression. The normalized results are expressed as mean relative polymerase
activity in relative to wild-type vRNPs at the corresponding temperature. Mock
represents the negative control without vRNP complexes. Error bars represent one
standard deviation (N¼3, npo0.05, by t-test).
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have virulence comparable to PB2-627E, 627R and 627-K viruses.
This indicates that a charged amino acid side-chain at this position
is not absolutely essential to achieve a robust replication in mice.
In addition to the amino acid change at PB2-627 position, the
RNA sequence of the PB2 gene may also have a role in modulating
the viral ﬁtness. Most of the PB2-627 mutants tested consist of two
(I, L, R, S, V and A) or even three (C) nucleotide changes at the
codon compared to the wild-type PB2-627K or the avian signature
PB2-627E (Supplementary table). It is not known whether these
RNA sequence changes would have effects on the secondary
structure of the PB2 vRNA segment, which may affect the pheno-
type of a virus (Witteveldt et al., 2014).
Contrary to our in vivo ﬁndings, all of the introduced PB2-627
mutations were found to be stable in vitro and no mutation at this
position was detected after 10 serial passages in MDCK cells. This
demonstrates that the selection pressures from these in vitro
cultures to the PB2-627 position were different from those
imposed from in vivo conditions. We, however, detected a number
of point mutations at other PB2 positions in the passaged mutants.
Of the ﬁve reproducible mutations, four (309N, 504V, 591K and
701N) are compensatory mutations that could completely or
partially restore viral polymerase activities. PB2 591 and 701
positions are well-known markers for enhancing viral polymerase
activities in mammalian cells. The PB2-D701N mutation can
increase the binding of PB2 to importin-α1 in mammalian cells,
leading to enhanced viral polymerase activity (Gabriel et al., 2005,
2008; Zhou et al., 2013). The PB2-Q591R mutation can compensate
for the absence of PB2-627K in mammalian adaptation (Liu et al.,
2012; Mehle and Doudna, 2009; Yamada et al., 2010). The PB2-
I504V mutation was found to have the strongest stimulatory
effects on the viral polymerase activities. This mutation has
previously been shown to have a role in regulating viral polymer-
ase activity, viral virulence and host RNA polymerase II degrada-
tion (Llompart et al., 2014), but the relationship between these
events is yet to be fully understood. In contrast, little is known
about the biological function of PB2-309 position. The residue is
close to the cap binding domain of PB2, but none of the resolved
PB2 protein structures can provide information regarding this
position. We are also not aware of any biological or biochemical
studies at this position. Knowing the fact that the PB2-D309N
mutation can be repeatedly found in two different PB2-627
mutants and the mutation can signiﬁcantly enhance viral poly-
merase activity, in both human and avian vRNPs, further investi-
gation of this PB2-D309N mutation is warranted.
This study not only characterizes a number PB2-627 mutants,
but also demonstrates the combine use of site-directed random
mutagenesis and reverse genetics techniques (Dominy and
Andrews, 2003; Hoffmann et al., 2001; Valetti and Gilardi, 2013)
to generate recombinant inﬂuenza viruses with random mutations
at the position of interest. With this approach, much effort can be
saved for generating multiple mutant viruses with different amino
acids by site mutagenesis. In addition, our results suggest that
viruses with “suboptimal” viral polymerase activities attempt to
restore their ﬁtness by introducing mutations at other vRNP
regions. Although it is not known whether these compensatory
mutations directly cooperate with the PB2-627 residue in the virus
lifecycle, we reason that our approach is a good strategy to identify
novel mutations that can enhance viral polymerase.
In summary, our results demonstrate that inﬂuenza virus can
tolerate a wide range of amino acids at the PB2-627 position.
Viruses with mutations at this position displayed different proper-
ties in vitro and in vivo. The stability of these PB2-627 mutations
in vitro and in vivo is different, indicating that the selection
pressures imposed by the in vitro and in vivo conditions on the
PB2-627 position are different and that inﬂuenza virus use
different strategies to restore the viral ﬁtness under these
conditions. Further characterization of these PB2 mutants and
their derivatives might help to better understand some speciﬁc
biological events of inﬂuenza viral polymerase.
Materials and methods
Cell cultures and viruses
MDCK cells, 293T cells, speciﬁc pathogen free embryonated
chicken eggs and DF-1 cells were used in this study. MDCK cells
and 293T cells were maintained in minimum essential medium
(MEM) supplemented with 10% fetal bovine serum (FBS) (Life
Technologies). DF-1 cells were maintained in Dulbecco's modiﬁed
eagle medium (DMEM) supplemented with 10% FBS. Inﬂuenza
viruses of PR8 and G1 backgrounds were generated by reverse
genetics technique as described (Hoffmann et al., 2000).
Generation of recombinant viruses with random amino acid at
PB2-627
Introduction of random mutations at the 627 position of PR8-
PB2 was done by site-directed random mutagenesis by PCR
(Valetti and Gilardi, 2013). The pHW2000-PR8-PB2 plasmid was
ampliﬁed using inverse PCR with degenerated forward primer
(50-CCANNNCAAAGTAGAATGCAGTTCTCC, N¼any base) and reverse
primer (50-TGGAGCGGCTGCGAAGGGAAG), followed by blunt-end
ligation, to introduce the random mutation at PB2-627 position
(Dominy and Andrews, 2003). The repaired circular PB2 plasmid
DNA was gel puriﬁed using a gel extraction kit (Qiagen). The
mutated PB2 plasmid preparation was transfected, together with
the other 7 plasmids encoding the remaining inﬂuenza viral
segments, into 293T cells to generate recombinant PR8 mutants
by reverse genetics technique (Hoffmann et al., 2000). The progeny
viruses were harvested 48 h post-transfection and were inoculated
into MDCK cells (mammalian system) or 10-day-old embryonated
chicken eggs (avian system). The infected cells and eggs were
incubated for 72 h at 37 1C. The progeny viruses from the infected
MDCK cells and eggs were plaque puriﬁed in MDCK cells and
DF-1 cells, respectively. Well isolated plaques were picked and
cultured in the corresponding cells. The full-length PB2 gene of each
plaque puriﬁed progeny virus was sequenced by standard dideoxy
sequencing.
Luciferase reporter assay
The polymerase activities of vRNPs carrying different PB2 627
mutations in avian (DF1) and human (293T) cells were determined
by luciferase reporter assays (Li et al., 2009). Plasmid mixtures
were prepared by mixing pcDNA plasmids expressing PB2 (wide
type or its mutants), PB1, PA and NP proteins together with pPolI-
Luc-NS and pMax-GFP. For determination of polymerase activity in
avian DF-1 cells, the promoter of the pPolI-Luc-NS plasmid was
replaced with an avian promoter. The plasmid mixtures were
transfected into cells seeded on a 96-well culture plate and
transfected cells were incubated at 37 1C or 39 1C for 48 h. The
transfected cells were then lysed by Steady-Glo luciferase assay
substrate solution (Promega) for 5 min. The luciferase activities
were determined by the luminescence measured with a lumin-
ometer (Perkin-Elmer) and the data were normalized with expres-
sion level of GFP (Li et al., 2009).
Viral growth kinetics assay
MDCK or DF-1 cells were grown on 24-well culture plates to
conﬂuence. The mammalian and avian cells were infected by the
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viruses at MOI of 0.01 and 0.1 respectively. After 1 h of viral
adsorption, the virus inoculum was removed and the cells were
brieﬂy washed with acidic buffer (0.9% NaCl solution of pH 2) to
inactivate any free, unattached viral particles (Yen et al., 2005). The
cells were then washed with PBS and replenished with virus
culture medium (MEM supplement with 1 μg/ml TPCK trypsin for
MDCK cells and DMEM supplement with 0.2% FBS and 1 μg/ml
TPCK trypsin for DF-1 cells). The cells were incubated at 37 1C or
39 1C. Samples were harvested at different post-infection time
points as indicated. Viral titers of the harvested samples were
determined by standard plaque assays using MDCK cells.
In vivo pathogenicity study
Female BALB/c mice of 4–6 week old were used for the in vivo
pathogenicity studies. Mice were infected with 1000 TCID50 of
rescued viruses (N¼6 per group) via intranasal route. Infected
mice were monitored and weighed for 14 consecutive days after
infection. Mice with weight loss of more than 30% of the initial
body weight were humanely euthanized.
To determine the lung viral titer of the infected mice, they were
infected with the rescued viruses as describe above. The mice were
humanely euthanized at day 3 or 6 post-infection (N¼3 per
group). The harvested lungs were homogenized in 1 ml of ice-
cold PBS. The viral titer of the lung homogenate was determined
by standard TCID50 assay using MDCK cells.
Two mice from each group were euthanized when they are
close to the experimental endpoint (day 6 post-infection for PB2-
627K, 627I and 627R; day 12–14 post-infection for PB2-627L, 627S,
627V, 627A, 627C and 627Q). The lungs were dissected and were
homogenized. Viral RNA was extracted from the lung homoge-
nates with the viral RNA extraction kit (Qiagen). DNA sequences of
the full-length PB2 genes of the progeny viruses obtained from
the lung homogenates were determined by standard dideoxy
sequencing.
Serial passage of recombinant viruses with PB2-627 mutants
MDCK cells were infected by wild-type PR8 or its PB2 mutants
at MOI of 0.01. The infected cells were incubated at 37 1C or 39 1C
for 72 h before harvesting the virus cultures. The harvested
cultures and their diluted samples (1:10 and 1:100 dilutions) were
inoculated into MDCK cells. Virus cultures from cells infected with
the most diluted samples that still showed cytopathic effects were
selected for further serial passaging. Progeny viruses of each PB2
mutant were harvested at the 10th passage and the full-length PB2
of each passaged mutant was determined by standard dideoxy
sequencing.
Statistical analysis
Unless otherwise speciﬁed, data obtained in the experiments
were expressed as mean values of results of three individual
experiments (7standard deviation). Data were analyzed by Stu-
dent's t-test. The difference was considered signiﬁcant with po0.05.
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